Carly & Co. Hormone & Metabolic Health

Carly & Co. Hormone & Metabolic Health operates as a telehealth-focused clinic serving patients across Iowa and Nebraska, with founder Carly M. Parker, ARNP, holding specialized certification in obesity medicine. The practice addresses the intersection of metabolic dysfunction, hormone imbalance, and weight regulation through evidence-based interventions that include prescription peptide therapy, bioidentical hormone replacement, and comprehensive metabolic assessments. Based in Winterset, Iowa, the clinic provides virtual consultations that allow patients throughout both states to access specialized care without geographic limitations, combining the convenience of remote medicine with the clinical rigor of board-certified obesity medicine protocols.

Carly & Co. Hormone & Metabolic Health offers an extensive peptide therapy program with 5 different peptides available, including growth hormone secretagogues like Sermorelin, tissue repair compounds such as BPC-157, and other specialized compounds. Treatment selection is individualized based on comprehensive health assessments and patient goals.

Carly M. Parker brings her advanced practice registered nurse credentials and obesity medicine specialization to a patient population often underserved by conventional primary care models. Her approach integrates detailed lab interpretation—including comprehensive hormone panels, metabolic markers, and inflammatory indicators—with personalized treatment plans that may combine peptide therapy, hormone optimization, nutritional guidance, and metabolic medications when clinically appropriate. The clinic's focus on root-cause medicine means patients receive explanations of how peptides like Sermorelin influence growth hormone pathways to improve lean muscle retention during weight loss, or how NAD+ supplementation supports mitochondrial function that declines with age and metabolic stress. This educational component helps patients understand the biological mechanisms behind their symptoms and the rationale for each intervention.

Patients engaging with Carly & Co. begin with a comprehensive telehealth intake that includes medical history review, current symptom assessment, and discussion of previous weight management or hormone therapy attempts. Following initial consultation, Parker orders appropriate laboratory testing, which patients complete locally, with results reviewed in a follow-up virtual visit where treatment recommendations are finalized. Peptide protocols are shipped directly to patients with detailed administration instructions, dosing schedules, and guidance on what to monitor. Follow-up appointments track progress through symptom resolution, repeat labs, and body composition changes, with treatment adjustments made based on individual response. The telehealth model eliminates travel barriers for rural Iowa and Nebraska residents who would otherwise lack access to obesity medicine specialists and peptide therapy expertise in their immediate communities.

What distinguishes this Winterset-based practice is the combination of Parker's obesity medicine certification—a credential requiring additional training beyond standard nurse practitioner education—with a willingness to incorporate peptide therapies that many conventional practices overlook. The clinic's 5.0-star rating across patient reviews reflects satisfaction with both clinical outcomes and the accessibility of care, particularly for patients managing complex metabolic conditions that require ongoing monitoring and protocol refinement. For Iowa and Nebraska residents seeking hormone optimization and metabolic health support that extends beyond standard diet-and-exercise advice, Carly & Co. offers specialized interventions delivered through a convenient telehealth platform, making advanced peptide and hormone therapies accessible to patients across both states without requiring in-person clinic visits.